Related Experiment Videos
Endoscopic hemoclip treatment for bleeding peptic ulcer
World Journal of Gastroenterology
|January 31, 2002
Summary
Endoscopic hemoclip therapy effectively treated bleeding peptic ulcers, achieving a 93% overall hemostasis rate with a low 8% rebleeding rate. This safe and efficient method shows promise for managing peptic ulcer hemorrhage.
Area of Science:
- Gastroenterology
- Endoscopic Surgery
- Hemorrhage Control
Background:
- Peptic ulcer bleeding is a significant cause of gastrointestinal morbidity.
- Effective endoscopic hemostasis is crucial for managing active bleeding.
- Hemoclip application offers a minimally invasive approach.
Purpose of the Study:
- To evaluate the efficacy and safety of endoscopic hemoclip therapy.
- To assess the hemostatic success rate in patients with bleeding peptic ulcers.
- To determine the rebleeding rates and complications associated with hemoclip placement.
Main Methods:
- Prospective study of 40 patients with bleeding peptic ulcers (F1a and F1b activity).
- Utilized a novel rotatable clip-device (MD850) for endoscopic hemoclip application.
- Repeated endoscopy and re-clipping were performed as needed for persistent or recurrent bleeding.
Main Results:
- Achieved an initial hemostatic rate of 95% and an overall hemostasis rate of 93%.
- The rebleeding rate was low at 8%.
- Hemostasis was 100% in patients without shock, and 71-83% in patients with shock, with no observed complications.
Conclusions:
- Endoscopic hemoclip placement is an effective and safe treatment for bleeding peptic ulcers.
- Improvements in clip devices enhance procedure efficiency and ease of use.
- Further research into endoscopic hemoclipping for peptic ulcer hemorrhage is warranted.